Although TMZ is BBB permeable and is less myelotoxic than other drugs available for GBM [13], unfortunately, mutant TP53 confers TMZ resistance by up-regulating MGMT expression in T98G and U138 GBM cell lines [14]. This evidence concerns the gene MGMT and glioblastoma.